- Lobbying
- Lobbying by UCB, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Erik Olson | Chief of Staff - Rep. Ron Kind (D-WI) |
Michael Spira | Chief of Staff - Rep. McCarthy (D-NY); Deputy Chief of Staff - Rep. Perlmutter (D-CO) |
Elizabeth Lee | Legislative Aide - Sen. Baldwin (D-WI); Fellow - Sen. Clinton (D-NY); Special Assistant, Office of the Secretary, Department of Health & Human Services; Senior Policy Advisor, HRSA, Department of Health & Human Services |
Grant Couch | Staff Assistant, Legislative Correspondent, Legislative Aide - Sen. Ron Wyden (D-OR) |
Melissa Francis | Legislative Director - Rep. Bill Archer (R-TX) |
Jon Pyatt | Chief of Staff - Rep. Cheri Bustos (D-IL); Legislative Counsel, Deputy Chief of Staff, Floor Assistant - Rep. Debbie Wasserman Schultz (D-FL) |
Stephanie Silverman | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Registration
Issue(s) they said they’d lobby about: Matters related to innovation in, and patient access to, biopharmaceutical therapies..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate